Clinical Trials Browser

Phase 2 × HER2-positive Gastric Cancer × Capecitabine × Clear all

NCT06998771 2025-05-31

JSKN003 Combined Treatment of HER2-positive Gastric Cancer

Phase 2 Not yet recruiting

Gastrointestinal

HER2-positive Gastric Cancer